| Literature DB >> 23839968 |
Elaine Tan1, Ruben T Almaraz, Hargun S Khanna, Jian Du, Kevin J Yarema.
Abstract
Metabolic oligosaccharide engineering (MOE) refers to a technique where non-natural monosaccharide analogs are introduced into living biological systems. Once inside a cell, these compounds intercept a targeted biosynthetic glycosylation pathway and in turn are metabolically incorporated into cell-surface-displayed oligosaccharides where they can modulate a host of biological activities or be exploited as "tags" for bio-orthogonal and chemoselective ligation reactions. Undertaking a MOE experiment can be a daunting task based on the growing repertoire of analogs now available and the ever increasing number of metabolic pathways that can be targeted; therefore, a major emphasis of this article is to describe a general approach for analog design and selection and then provide protocols to ensure safe and efficacious analog usage by cells. Once cell-surface glycans have been successfully remodeled by MOE methodology, the stage is set for probing changes to the myriad cellular responses modulated by these versatile molecules. Curr. Protoc. Chem. Biol. 2:171-194Entities:
Keywords: ManNAc analogs; glycosylation; selectin‐based adhesion; sialic acid glycoengineering
Year: 2010 PMID: 23839968 PMCID: PMC5757159 DOI: 10.1002/9780470559277.ch100059
Source DB: PubMed Journal: Curr Protoc Chem Biol ISSN: 2160-4762